Barclays Maintains Equal-Weight on Medpace Holdings, Lowers Price Target to $450

Benzinga Newsdesk www.benzinga.com Neutral 68.4%

Neg 0% Neu 68.4% Pos 0%

Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and lowers the price target from $500 to $450.